UCT and McMaster University Lead Clinical Trial Aimed at Reducing HIV-related Deaths in Africa
A new trial will test a low-cost antibiotic aimed at reducing deaths among 8 000 patients with advanced HIV who are starting or restarting anti-retroviral therapy (ART), a combination of drugs to treat HIV.
The study, called REVIVE, is…